Many blood cancers can be treated with a potentially curative stem cell transplant, but this procedure introduces a serious complication risk that can become deadly. A new type of cell therapy gives ...

Orca Bio's manufacturing facility in Sacramento, California. Orca Bio has become a commercial-stage company with the FDA approval of Tregzi, a cell-based immunotherapy designed to prevent graft-versus ...

Add Yahoo as a preferred source to see more of our stories on Google. Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020.

Complexity is inherent to cell and gene therapy and that includes its manufacturing, where moving towards producing products at a commercial scale continues to challenge companies in the sector. To ...

Financing extension led by 8VC to advance LTS-201 as a potential significant commercial opportunity in Huntington’s disease (IND expected in 3Q 2026) Potential clinical proof-of-concept of Latus ...

Cellares reported that the first two patients have been dosed with Cabaletta Bio’s investigational CAR T cell therapy rese-cel (resecabtagene autoleucel) manufactured on Cellares’ Cell Shuttle™ ...

Designation granted by FDA recognizes the potential of plixorafenib, a novel, investigational paradox breaker and BRAF inhibitor, to provide substantial improvement over available therapies First ...

In 2021, dermatologist David Ozog was on holiday with his family in the Bahamas, when his 18-year-old son had a massive stroke. The teenager was airlifted to Florida, and then to Chicago for surgery.

Sartorius’ life science group is launching an integrated system for the production and quality control (QC) of autologous cell therapies. The modular Eveo Cell Therapy Platform is designed to address ...

Photobiomodulation uses red and near-infrared light to modulate mitochondrial activity, cellular signaling, and inflammatory pathways, supporting tissue repair and physiological recovery. Clinical ...

NASHVILLE, TN, UNITED STATES, March 11, 2026 /EINPresswire.com/ — Dr. Garcia is confirmed to participate as a speaker at the 21st Century Healing: Beyond the ...

Just three months after further scaling back its support for the struggling hemophilia A gene therapy Roctavian, BioMarin is walking away altogether by pulling the treatment from the market. The move ...